Papers from every journal, all in one place. Create custom feeds.
Semaglutide may lower MACE in overweight patients with ASCVD without diabetes; leaves open long-term durability and broader applicability.
Cardiologist, Brigham and Women's Hospital
The fact that you can see benefits within 3 to 6 months points to other mechanisms that may be involved more rapidly than what we would typically look at in terms of weight change. He suggested that it might relate to inflammation, noting that hs-CRP is reduced quite quickly after starting semaglutide.
These 5 measures enable standardized, equitable AF quality assessment; extends guidelines into actionable public reporting and pay-for-performance standards.
Meta-analysis reveals improved coronary flow following intracoronary low-dose thrombolysis during primary PCI in STEMI, indicating therapeutic benefit without major bleeding.
Interventional Cardiologist, University of Alberta
In this contemporary meta-analysis of 4 randomized controlled trials, adjunctive intracoronary low-dose thrombolysis during primary PCI does not improve epicardial flow, myocardial perfusion, or clinical outcomes. Current evidence does not support its routine use, and this strategy should be considered contraindicated (class III) in contemporary practice.
LA strain identifies higher-risk ATTR-CM patients; extends vutrisiran benefits to slowing atrial myopathy.
CKM staging tracks with CV health and carotid metrics in young adults; leaves open whether staging improves long-term risk prediction.
Cardiologist, Boston Medical Center
The study shows that CKM syndrome staging and Life's Essential 8 are complementary for identifying adults younger than age 30 who may be on the fast track for arterial injury, plaque build-up and, ultimately, at higher risk for future cardiovascular events.
Subgroup findings in birisk diabetic ACS patients may support extended clopidogrel monotherapy; leaves open confirmation in dedicated trials.
Underrepresentation hinders variant interpretation and SCD care in African-descent patients; leaves open inclusive genomic studies to close equity gaps.
One-stop CA+LAAC appears feasible in AF; leaves open whether combined use improves outcomes versus staged procedures.
AI models show predictive promise for perioperative complications; leaves open routine use pending external validation and impact trials.
May aid early pericarditis screening via fused clinical-ECG data; leaves open prospective validation before clinical use.
Cardiologist, Cardiology Department, A.O.U. Città della Salute e della Scienza di Torino
In 6508 patients, including 902 with clinically confirmed pericarditis, the fused model outperformed either component alone, with an area under the receiver operating characteristic curve of 0.89 compared with 0.85 for the ECG model and 0.74 for the tabular model. At the selected threshold, the negative predictive value was 0.96, although the positive predictive value remained 0.48.